Back
Speaker illustration

Miss Anastasiia Filatova

National Medical Research Center of Cardiology, Moscow (Russian Federation)

Member of:

Heart Failure Association

Anastasiia Filatova graduated from Lomonosov Moscow State University, Faculty of Basic Medicine, and completed the two-year residency in cardiology in the Institute of Clinical Cardiology of National Medical Research Center of Cardiology. She is currently a junior research associate of the Laboratory of Cell Immunology in the Institute of Experimental Cardiology of National Medical Research Center of Cardiology (Moscow). Her scientific focus area: inflammatory and immune mechanisms of atherosclerosis progression, in particular, circulating pro- and anti-inflammatory subpopulations of lymphocytes and monocytes in patients with different stages of coronary and carotid atherosclerosis progression and the prognostic value of inflammatory markers in coronary stenting; immunomodulating properties of statins.

Presentations

Association of elevated lipoprotein(a) level and monocyte subsets with the severity of coronary atherosclerosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Inflammation and Immunity

Session: Chronic coronary syndromes: pathophysiology, treatment, and prognosis

Access
Thumbnail

Aging is accompanied by a decrease in the number of naive Tregs.

Event: ESC Preventive Cardiology 2021

Topic: Leukocytes, Inflammation, Immunity

Session: Moderated abstracts - Primary Care and Risk Factor Management

Access
Thumbnail

Patient adherence to statin therapy within 12 months after coronary stenting depending on regular or remote monitoring.

Event: ESC Preventive Cardiology 2021

Topic: Revascularisation

Session: ePosters

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb